Search filters

List of works by Morie A Gertz

+1q: amplifying the bad genes in myeloma

scientific article published on 16 January 2017

6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance

scientific article

6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis

scientific article published on 01 January 2007

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing

scientific article published on 13 February 2019

A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

scientific article published on June 2010

A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma

scientific article

A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?

scientific article published on June 2013

A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death.

scientific article

A multicenter phase 2 trial of stem cell transplantation for immunoglobulin light-chain amyloidosis (E4A97): an Eastern Cooperative Oncology Group Study

scientific article published on 01 July 2004

A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL).

scientific article

A novel report of cig-FISH and cytogenetics in POEMS syndrome.

scientific article

A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma

scientific article published on 4 September 2017

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy

scientific article published on 23 February 2017

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

scientific article published in January 2005

A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin

scientific article published on 31 December 2012

A phase II study of high-dose methylprednisolone in refractory or relapsed multiple myeloma

scientific article published on 01 December 1995

A phase II trial of imatinib in patients with refractory/relapsed myeloma

scientific article published on January 2006

A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma

scientific article published on 20 August 2012

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

scientific article published on 18 January 2007

A practical review on carfilzomib in multiple myeloma

scientific article published on 19 February 2016

A reappraisal of immunoglobulin variable gene primers and its impact on assessing clonal relationships between PB B cells and BM plasma cells in AL amyloidosis

scientific article published on 10 September 2011

A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis

scientific article published on 23 July 2020

A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine

scientific article published on 01 April 1997

A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.

scientific article published on 26 May 2005

A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis

scientific article published on 14 April 2020

Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death.

scientific article published on May 2015

Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma

scientific article published on 01 September 1999

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

scientific article published on 5 January 2006

Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma

scientific article published on 9 March 2004

Acquired Fanconi's syndrome associated with monoclonal gammopathies

scientific article

Acquired transthyretin amyloidosis after domino liver transplant: Phenotypic correlation, implication of liver retransplantation

scientific article published on 13 June 2017

Activity of bortezomib administered once every 3 weeks for treatment of relapsed multiple myeloma.

scientific article

Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis

scientific article

Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide

scientific article published on 12 December 2020

Acute hyperviscosity: syndromes and management

scientific article published on 13 August 2018

Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis

scientific article published on 11 November 2011

Acute leukemia and cytogenetic abnormalities complicating melphalan treatment of primary systemic amyloidosis

scientific article published on 01 March 1990

Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation

scientific article published in January 2005

Acute weight gain and diastolic dysfunction as a potent risk complex for post stem cell transplant atrial fibrillation.

scientific article published in August 2009

Advanced skeletal imaging redefines the management of plasma cell disorders

scientific article published on 20 January 2015

Advances in the treatment of amyloidosis

scientific article published on 01 June 2007

Advances in the treatment of hereditary transthyretin amyloidosis: A review

scientific article published on 01 August 2019

Allaying and alleviating amyloid agony and anxiety.

scientific article published in April 2013

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

scientific article published on 01 June 2006

Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 Samples

scientific article published on 01 September 2020

Amyloid goiter as a manifestation of primary systemic amyloidosis

scientific article published in January 2007

Amyloid localized to tenosynovium at carpal tunnel release. Immunohistochemical identification of amyloid type

scientific article published on 01 February 1992

Amyloidosis

scientific article published on 01 January 2005

Amyloidosis

scientific article published on 01 January 2009

Amyloidosis and POEMS syndrome

scientific article

Amyloidosis and Waldenström's macroglobulinemia

scientific article

Amyloidosis with IgM monoclonal gammopathies ⬇️

scientific article published on April 1, 2003

Amyloidosis.

scientific article

Amyloidosis: diagnosis and management

scientific article

Amyloidosis: pathogenesis and new therapeutic options.

scientific article

Amyloidosis: recognition, confirmation, prognosis, and therapy

scientific article published on 01 May 1999

An unusual neurological complication of light chain amyloidosis

scientific article published on 16 September 2009

Analysis of Clinical Factors and Outcomes Associated with Non-Utilization of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant Eligible Patients with Multiple Myeloma

scientific article published on 12 April 2018

Analysis of somatic hypermutation and antigenic selection in the clonal B cell in immunoglobulin light chain amyloidosis (AL).

scientific article

Antibody based immunotherapy for multiple myeloma: it's about time

scientific article

Aplastic anemia due to tocainide

scientific article published on February 1986

Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial

scientific article published on 7 January 2017

Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature

scientific article published on 20 July 2010

Attitudes about when and how to treat patients with AL amyloidosis: an international survey.

scientific article published on 31 August 2017

Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy

scientific article published on 14 July 2008

Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis

scholarly article by M Hasib Sidiqi et al published March 2019 in Biology of Blood and Marrow Transplantation

Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75

scientific article published on 20 June 2018

Autologous attack on amyloidosis

scientific article published on 01 July 2006

Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma.

scientific article

Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia

scientific article published on August 2006

Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy

scientific article

Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report

scientific article published on 20 October 2010

Autologous stem cell transplant for multiple myeloma patients 70 years or older

scientific article published on 4 July 2016

Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative

scientific article

Autologous stem cell transplantation and IgM amyloidosis

scientific article published on June 2006

Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents

scientific article published on 04 December 2020

Autologous stem cell transplantation for primary systemic amyloidosis

scientific article

Autologous stem cell transplantation for relapsed and primary refractory myeloma

scientific article published on 01 June 1999

Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiency

scientific article published on 25 July 2015

Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age.

scientific article published on December 2003

Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis

scientific article published in August 2008

Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal function

scientific article published on 08 April 2019

Autosomal dominant familial Mediterranean fever-like syndrome with amyloidosis

scientific article

Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner

scientific article published on 23 September 2020

Baby, it's cold outside! ⬇️

scientific article published on June 21, 2012

Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a 'graft versus host'-like syndrome and poor outcomes

scientific article published on 11 March 2020

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

scientific article published on 03 April 2018

Bendamustine, lenalidomide, and dexamethasone (BRD) is highly effective with durable responses in relapsed multiple myeloma.

scientific article published on 2 September 2015

Beta 2-microglobulin predicts survival in primary systemic amyloidosis

scientific article published on November 1990

Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation

scientific article published on 12 October 2016

Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma

scientific article published on 01 June 1999

Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients

scientific article published on 23 July 2008

Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis

scientific article published on 25 February 2020

Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL)

scientific article published on 01 November 2000

Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis

scientific article published on 01 July 2002

Bone marrow angiogenesis in multiple myeloma: effect of therapy

article

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma

scientific article published on 01 March 1999

Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

scientific article published on 22 November 2019

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma

scholarly article by M Hasib Sidiqi et al published 8 November 2018 in Blood Cancer Journal

Bortezomib-based combination regimens in myeloma: more is not necessarily better

scientific article published on 28 January 2014

Burden of hereditary transthyretin amyloidosis on quality of life

scientific article published on 13 June 2019

Caring (Really) for Patients Who Use Alternative Therapies for Cancer ⬇️

scientific article published on May 1, 2003

Caring for the terminally ill patient with hematologic malignancies

scientific article

Case vignettes and other brain teasers of monoclonal gammopathies

scientific article published on January 1, 2012

Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis

scientific article published on 15 February 2011

Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma

scientific article published on 16 June 2017

Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma

scientific article published on 28 August 2020

Characteristics of exceptional responders to lenalidomide-based therapy in multiple myeloma.

scientific article

Characteristics of late transplant-associated thrombotic microangiopathy (TA-TMA) in patients who underwent allogeneic hematopoietic stem cell transplantation

scientific article published on 02 July 2020

Characteristics of long-term survivors with multiple myeloma: A National Cancer Data Base analysis

scientific article published on 28 June 2019

Characterization and prognostic implication of delayed complete response in AL amyloidosis

scientific article published on 23 November 2020

Chemoprevention for smoldering multiple myeloma: not ready for prime time ⬇️

scientific article published on 07 May 2013

Chromosomal abnormalities in systemic amyloidosis

article

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma

scientific article published on 01 February 2003

Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis

scientific article published on 05 September 2002

Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma

scientific article published on 16 June 2005

Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry.

scientific article published on 16 November 2016

Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma

scientific article

Classification of amyloidosis by the detection of clonal excess of plasma cells in the bone marrow

scientific article published on 01 July 1991

Clinical Course and Prognosis of Non-Secretory Multiple Myeloma.

scientific article

Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies

scientific article published on 5 May 2016

Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both

scientific article published on 12 May 2015

Clinical characteristics and outcomes in biclonal gammopathies

scientific article published on 3 February 2016

Clinical characteristics and treatment outcomes in IgE multiple myeloma: A case-control study.

scientific article

Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities

scientific article published on 01 August 2020

Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy

scientific article published on 11 April 2016

Clinical course and prognosis of non-secretory multiple myeloma

scientific article

Clinical course of patients with relapsed multiple myeloma

scientific article published in July 2004

Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics

scientific article

Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma ⬇️

scientific article

Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney

scientific article published on 07 November 2011

Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis

scientific article published on 05 March 2019

Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma

scientific article published on 11 January 2010

Clinical implication of centrosome amplification in plasma cell neoplasm

scientific article published on 22 December 2005

Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy

scientific article published on 23 June 2005

Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.

scientific article published on 29 April 2009

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains

scientific article published on 18 September 2017

Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia

scientific article published on 29 March 2017

Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma

scientific article published in November 1999

Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma

scientific article published on 17 February 2017

Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial.

scientific article published on 14 September 2009

Clinicopathologic Correlations in Multiple Myeloma: A Case Series of 190 Patients With Kidney Biopsies

scientific article published on 13 March 2012

Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor

scientific article published on January 2001

Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis

scientific article published on 21 October 2013

Cold agglutinin disease

scientific article (publication date: April 2006)

Cold agglutinin disease and cryoglobulinemia

scientific article

Cold hemolytic syndrome

scientific article published on January 2006

Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment

scientific article published on 06 October 2020

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma

scientific article published on 23 August 2005

Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial

scientific article

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

scientific article published in November 2002

Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma.

scientific article published on 16 August 2018

Comparative analysis of staging systems in AL amyloidosis

scientific article published on 23 January 2019

Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma

scientific article published on 10 November 2008

Computed tomography for diagnosis of hepatic rupture in primary systemic amyloidosis ⬇️

scientific article published on 01 July 1991

Conflicts of interest, authorship, and disclosures in industry-related scientific publications

scientific article

Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis

scientific article published on 05 April 2012

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

scientific article published on 03 February 2011

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.

scientific article published on 25 October 2013

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.

scientific article

Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

scientific article published on 29 July 2020

Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond

scientific article published on 01 April 2019

Correction: Waldenström macroglobulinemia treatment algorithm 2018.

scientific article

Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma

scientific article

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients

scientific article published on 11 December 2020

Corrigendum to “Quantitative analysis of clonal bone marrow CD19+ B cells: Use of B cell lineage trees to delineate their role in the pathogenesis of light chain amyloidosis” [Clin. Immunol. 120 (2006) 106–120]

scholarly article published in Clinical Immunology

Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization

scientific article published on 23 August 2012

Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myeloma

scientific article published on 18 August 2014

Critiquing cryos

scientific article published on 01 June 2008

Current Trends in Diagnosis and Management of Cardiac Amyloidosis ⬇️

scientific article published on February 1, 2013

Current and Emerging Treatments for Waldenström Macroglobulinemia

scientific article published on 18 August 2020

Current role of high dose chemotherapy in the management of multiple myeloma

scientific article published on 11 December 2018

Current status of stem cell mobilization

scientific article published on September 2010

Current status of stem cell transplantation for multiple myeloma

scientific article

Current therapy for multiple myeloma

scientific article

Current therapy of myeloma induced renal failure

scientific article published on May 2008

Current treatment options for Waldenström macroglobulinemia

scientific article published on August 2008

Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients.

scientific article published on 4 January 2016

Cyclophosphamide Mobilization Does Not Improve Outcome in Patients Receiving Stem Cell Transplantation for Multiple Myeloma

scientific article published on 01 March 2006

Cytogenetic Abnormalities Correlate with the Plasma Cell Labeling Index and Extent of Bone Marrow Involvement in Myeloma

article

Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

scientific article published on 09 October 2019

Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response

scientific article published on 11 August 2020

Daratumumab as successful initial therapy for AL amyloidosis with nerve involvement

scientific article published on 11 March 2020

Daratumumab for the treatment of AL amyloidosis

scientific article published on 22 July 2018

Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis

scientific article published on 28 September 2018

Death during coronary angiography in a woman with cardiac amyloidosis

scientific article published on 01 June 2006

Deciding on the therapy of multiple myeloma using genetic risk stratification ⬇️

scientific article published on January 24, 2011

Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?

scientific article published on 01 July 2018

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

scientific article

Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma

scientific article published on 21 October 2019

Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma

scientific article published on 01 July 2000

Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression

article

Delineation of the timing of second line therapy post- autologous stem cell transplant in patients with AL amyloidosis

scientific article published on 14 August 2017

Deposition of amyloid proteins in the epicardial coronary arteries of 58 patients with primary systemic amyloidosis

scientific article published on 01 March 2007

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria

scientific article published on 20 February 2018

Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria

scientific article published on 01 January 2019

Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis

scientific article published on 18 November 2020

Detection of monoclonal plasma cells in the peripheral blood of patients with primary amyloidosis ⬇️

scientific article published on 01 February 1998

Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma

scientific article published on 01 March 1995

Developing a clinical trial unit to advance research in an academic institution

scientific article published on 07 October 2015

Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma

scientific article published on 16 May 2019

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

scientific article published on 08 August 2017

Diagnosing primary amyloidosis

scientific article published on 01 December 2002

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

scientific article published on 05 January 2017

Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

scientific article

Diagnosis and management of smoldering multiple myeloma: the razor's edge between clonality and cancer

scientific article

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting

scientific article published on 05 December 2019

Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis

scientific article

Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients

scientific article published in November 1992

Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplant

scientific article published on 01 May 2020

Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography

scientific article published in August 2004

Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?

article by Eli Muchtar et al published 12 March 2018 in Amyloid

Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs

scientific article published on October 2010

Does stem cell transplantation have a role in the management of multiple myeloma, 2009?

scientific article published on 01 January 2009

Domino liver transplantation as a cause of acquired familial amyloid polyneuropathy

Doppler characterization of left ventricular diastolic function in cardiac amyloidosis

scientific article published in April 1989

Early Data on Long-Term Efficacy and Safety of Inotersen in Patients With Hereditary Transthyretin Amyloidosis: A 2-Year Update From the Open-Label Extension of the NEURO-TTR Trial

scientific article published on 28 April 2020

Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma

scientific article published on 01 February 1999

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis

scientific article published on 01 February 2005

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

scientific article published on 01 August 2001

Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.

scientific article

Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents

scientific article

Early results of a phase I trial of oblimersen sodium for relapsed or refractory Waldenstrom's macroglobulinemia

scientific article

Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma.

scientific article published on 25 August 2011

Effect of complete response on outcome following autologous stem cell transplantation for myeloma

scientific article published on 01 November 2000

Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response

scientific article published on 01 October 2007

Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia ⬇️

scientific article published on November 1, 2001

Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.

scientific article

Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma.

scientific article published in March 2004

Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma

scientific article published on 25 October 2017

Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials

scientific article published on 11 August 2017

Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma

scientific article

Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma

scientific article published on 05 April 2011

Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement

scientific article published in February 2005

Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation

scientific article published on 13 November 2017

Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation

scientific article

Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival

scientific article published in July 2001

Eliminating the complete response penalty from myeloma response assessment

scientific article published on 01 March 2008

Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma

scientific article published on 21 July 2015

Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells

scientific article published on 08 January 2020

Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.

scientific article

Erratum: International uniform response criteria for multiple myeloma

scholarly article published in Leukemia

Erratum: International uniform response criteria for multiple myeloma

article

Erratum: Long-term outcome of patients with multiple myeloma-related advanced renal failure following auto-SCT

scholarly article published in Bone Marrow Transplantation

Erratum: Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant-ineligible patients with multiple myeloma: a meta-analysis

scholarly article published in Leukemia

Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1.

scientific article published on 17 March 2011

Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation

scientific article published on 13 July 2012

Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie

scientific article

Evolution of Hematopoietic Cell Transplantation for Immunoglobulin Light Chain Amyloidosis

scientific article published on 13 October 2015

Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma

scientific article published on 29 July 2016

Excessive fluid accumulation during stem cell mobilization: a novel prognostic factor of first-year survival after stem cell transplantation in AL amyloidosis patients.

scientific article published on 21 July 2005

Exhausted and outnumbered: CD4+ T cells in the myeloma battlefield

scientific article published on 16 June 2020

Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy

scientific article published on 06 January 2020

Exploring the amyloid proteome in immunoglobulin-derived lymph node amyloidosis using laser microdissection/tandem mass spectrometry

scientific article

External beam radiation therapy for amyloidosis of the urinary bladder

scientific article published on 16 August 2017

Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma

scientific article published in May 2009

Factors influencing platelet recovery after blood cell transplantation in multiple myeloma ⬇️

scientific article published on 01 September 1997

Familial amyloidosis: a study of 52 North American-born patients examined during a 30-year period

scientific article published on 01 May 1992

Fatal disseminated aspergillosis following sequential heart and stem cell transplantation for systemic amyloidosis

scientific article published in May 2001

Fatal pulmonary toxicity related to the administration of granulocyte colony-stimulating factor in amyloidosis: a report and review of growth factor-induced pulmonary toxicity

scientific article

Fever of unknown origin caused by multiple myeloma: a report of 9 cases

scientific article published on June 2002

Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis

scientific article published on 11 July 2019

Finishing off fibrils

scientific article published on 01 August 2009

First report of MYD88 L265P somatic mutation in IgM-associated light-chain amyloidosis

scientific article published on 31 March 2016

First report of MYD88L265P somatic mutation in IgM-associated light chain amyloidosis

First report of safety and efficacy of daratumumab in 2 cases of advanced immunoglobulin light chain amyloidosis.

scientific article

First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction

scientific article

Fish demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosis

scientific article published on 01 October 2000

Fitting mSMART Into the Current Clinical Management of Waldenström Macroglobulinemia-Reply

scientific article published in February 2018

Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points.

scientific article published on 17 February 2006

Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system

scientific article published on 8 December 2005

Frequencies and geographic distributions of genetic mutations in transthyretin- and non-transthyretin-related familial amyloidosis

scientific article published on 07 October 2014

Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis

article

Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma

scientific article

Genetic aberrations and survival in plasma cell leukemia

scientific article published on 24 January 2008

Genetic variants in DNA repair pathways are not associated with disease progression among multiple myeloma patients

scientific article published on 12 October 2013

Genomic abnormalities in monoclonal gammopathy of undetermined significance

scientific article published on 01 August 2002

Genotype, echocardiography, and survival in familial transthyretin amyloidosis.

scientific article published on 16 October 2013

Globular amyloid deposits isolated to the small bowel: a rare association with AL amyloidosis

scientific article published on 01 January 2007

Glycosylation of Immunoglobulin Light Chains is Highly Prevalent in Cold Agglutinin Disease

scientific article published on 01 May 2020

Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits

scientific article published on May 2015

Hematology patient reported symptom screen to assess quality of life for AL amyloidosis

scientific article published on 9 February 2017

Hematopoietic recovery kinetics predicts for poor CD34+ cell mobilization after cyclophosphamide chemotherapy in multiple myeloma

scientific article published on 29 September 2011

Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients

scientific article published on 29 October 2019

Hemorrhagic cystitis complicating bone marrow transplantation

scientific article (publication date: February 1992)

Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients

scientific article published on 01 July 1988

Herbs for hematology

scientific article published on 01 August 2010

Hereditary ATTR amyloidosis: a single-institution experience with 266 patients

scientific article published on 27 May 2015

Hereditary ATTR amyloidosis: burden of illness and diagnostic challenges

scientific article published in June 2017

Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial

scientific article published on 31 August 2018

High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis

scientific article published in August 2001

High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia

scientific article published on 24 April 2017

High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis

scientific article published on 08 January 2014

High-Dose Chemotherapy with Autotransplantation in AL Amyloidosis: A Flawed Meta-analysis

scientific article published on 15 September 2009

High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

scientific article published on 01 January 2008

High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma

scientific article

High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement

scientific article published on 6 December 2011

High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy

scientific article

High-risk multiple myeloma: a multifaceted entity, multiple therapeutic challenges

scientific article

How I treat cold agglutinin hemolytic anemia

scientific article published on 01 June 2019

How I treat cryoglobulinemia.

scientific article published on 31 October 2016

How we manage autologous stem cell transplantation for patients with multiple myeloma

scientific article

Hyperviscosity syndrome.

scientific article

Hyposplenism in primary systemic amyloidosis

scientific article published on 01 April 1983

I don't know how to treat amyloidosis

scientific article published on 01 July 2010

IAP antagonists induce anti-tumor immunity in multiple myeloma.

scientific article

IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma

scientific article published on 01 March 2002

IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia

scientific article published on 13 September 2012

Ibrutinib for the treatment of Waldenström macroglobulinemia

scientific article published on 02 July 2015

Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes

scientific article published on 29 August 2019

Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia

scientific article (publication date: 15 April 2009)

Identification of two groups of smoldering multiple myeloma patients who are either high or low producers of interleukin-1.

scientific article published on February 2006

Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival

scientific article

IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features

scientific article published on 28 November 2019

IgM Amyloidosis: Clinical Features in Therapeutic Outcomes ⬇️

scientific article published on February 1, 2011

IgM myeloma: A multicenter retrospective study of 134 patients

scientific article published on 6 April 2017

Immunoglobulin D amyloidosis: a distinct entity

scientific article published on 07 November 2011

Immunoglobulin Light Chain Amyloidosis: 2020 Update on Diagnosis, Prognosis, and Treatment

scientific article published on 08 April 2020

Immunoglobulin Light-Chain Amyloidosis: From Basics to New Developments in Diagnosis, Prognosis and Therapy

scientific article

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

scientific article

Immunoglobulin free light chains and solitary plasmacytoma of bone

scientific article

Immunoglobulin light chain amyloidosis

scientific article published on 18 December 2013

Immunoglobulin light chain amyloidosis and the kidney

scientific article

Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018.

scientific article

Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias

scientific article published on 02 September 2014

Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk‐stratification, and management ⬇️

scientific article published on February 1, 2011

Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment ⬇️

scientific article published on May 1, 2013

Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment

scientific article

Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment

scientific article published on September 2016

Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment

scholarly article by Morie A Gertz et al published September 2018 in American Journal of Hematology

Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL).

scientific article

Immunoglobulin light-chain amyloidosis: growing recognition, new approaches to therapy, active clinical trials

scientific article published on February 1, 2012

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

scientific article published on 23 May 2016

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type

Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type

scientific article published on 16 June 2016

Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia

scientific article published on 31 December 2019

Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk Cytogenetics

scientific article published on 20 January 2017

Impact of acquired del(17p) in multiple myeloma

scientific article published on 01 July 2019

Impact of additional cytoreduction following autologous SCT in multiple myeloma.

scientific article published on 16 June 2008

Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma

scientific article published on 19 March 2007

Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis

scientific article published on 23 July 2019

Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma

scientific article published on 21 October 2015

Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma

scientific article

Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation.

scientific article published on 29 April 2018

Impact of early relapse after auto-SCT for multiple myeloma.

scientific article published on 30 June 2008

Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).

scientific article published on 27 September 2017

Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma

scientific article published on 21 June 2007

Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis

scientific article published on 03 February 2020

Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma

scientific article published on 7 July 2016

Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT.

scientific article published on 10 March 2008

Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma

scientific article published on 20 February 2019

Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis

scientific article published on 21 December 2017

Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

scientific article published on 26 March 2009

Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivity

scientific article published on 30 December 2019

Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma

scientific article published on 02 October 2020

Implications of continued response after autologous stem cell transplantation for multiple myeloma

scientific article published on 17 July 2013

Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma

scientific article published on 20 November 2020

Importance of FISH genetics in light chain amyloidosis

scientific article published on 19 September 2017

Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma

scientific article

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

scientific article

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death

scientific article published on 26 January 2017

Improved survival in multiple myeloma and the impact of novel therapies

scientific article

Improvement in Gastrointestinal Symptoms From Light Chain Amyloidosis After Adalimumab Therapy

scientific article published on 01 July 2019

Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma

scientific article

Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains

scientific article published on 2 April 2008

Improving strategies for the diagnosis of cardiac amyloidosis

scientific article published on 15 July 2015

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

In vivo and in silico studies on single versus multiple transplants for multiple myeloma

scientific article published on 14 March 2007

Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989 ⬇️

scientific article published on April 1, 1992

Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma

scientific article published on 25 February 2011

Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation

scientific article published on 06 June 2013

Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients

scientific article published on 07 April 2020

Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis

scientific article published on 01 May 2018

Individualizing cancer therapy

scientific article published in September 2010

Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component

scientific article published on February 2009

Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation

scientific article published on 24 June 2016

Inhibitor of the thrombin time in systemic amyloidosis: a common coagulation abnormality

scientific article

Initial immunoglobulin M ?flare? after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia

scientific article published on 01 December 2004

Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response

scientific article published on 01 December 2004

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

scientific article published on 01 July 2018

Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis

scientific article published on 03 July 2019

Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis

scientific article published on 18 December 2019

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

scientific article

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

scientific article published on 25 June 2009

International uniform response criteria for multiple myeloma.

scientific article

Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category

scientific article

Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis

scientific article published on 04 May 2009

Intracardiac thrombosis and embolism in patients with cardiac amyloidosis

scientific article published on 05 November 2007

Is antisense nonsense?

scientific article published on 01 April 2009

Jaw claudication in primary systemic amyloidosis

scientific article published on 01 May 1986

Joint Pain and Proteinuria

scientific article published on 05 September 2019

KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation

scientific article published on 01 December 2020

KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer

scientific article published on 01 November 2020

Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders

scientific article published on 30 May 2018

Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis

scientific article published on 16 January 2015

Late‐onset noninfectious pulmonary complications after allogeneic bone marrow transplantation ⬇️

scientific article published on 01 March 1998

Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques

scientific article published on 9 December 2004

Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction

scientific article

Left ventricular device implantation for advanced cardiac amyloidosis

scientific article published on 6 March 2013

Lenalidomide - the new melphalan?

scientific article published on 14 April 2016

Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

scientific article

Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma

scientific article

Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial

scientific article published on 31 May 2011

Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial

scientific article

Life beyond bortezomib: increasing treatment options in refractory myeloma

scientific article published on 01 March 2016

Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma

scientific article published on 01 September 2000

Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation

scientific article published on 01 April 2018

Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response

scientific article

Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement.

scientific article published in July 2005

Localized AL amyloidosis of the colon: an unrecognized entity

scientific article published in March 2003

Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience

scientific article published on June 2016

Long-term Outcomes of Sequential Hematopoietic Stem Cell Transplantation and Kidney Transplantation: Single-center Experience

scientific article published on 07 October 2020

Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy

scientific article published on 18 February 2014

Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years

scientific article

Long-term outcome of autologous stem cell transplantation in light chain deposition disease

scientific article published on 4 January 2008

Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience

scientific article published on 11 March 2016

Long-term outcome of patients with mutiple myeloma-related advanced renal failure following auto-SCT

scientific article published on 05 August 2013

Long-term outcome of renal transplantation in light-chain deposition disease

scientific article published on 01 January 2004

Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.

scientific article published on 07 May 2013

Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience

scientific article

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis

scientific article published on 08 January 2020

Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation

scientific article published on 4 May 2011

Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma.

scientific article

Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma

scientific article published in October 2007

Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma

scientific article

Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia

scientific article

Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis

scientific article published on 18 July 2008

Long-term survival (10 years or more) in 30 patients with primary amyloidosis

scientific article published on 01 February 1999

Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003.

scientific article

Low levels of interleukin-1 receptor antagonist (IL-1RA) predict engraftment syndrome after autologous stem cell transplantation in POEMS syndrome and other plasma cell neoplasms.

scientific article published on 20 June 2013

Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization

scientific article

Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia

scientific article

Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations

scientific article

Lymphoplasmacytic lymphoma: What we need to know

scientific article published on 13 October 2015

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia.

scientific article published on 28 October 2017

Magnetic Resonance Elastography of Liver in Light Chain Amyloidosis

scientific article published on 23 May 2019

Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies

scientific article published on 28 October 2011

Making the Case to Study the Volume-Outcome Relationship in Hematologic Cancers

scientific article published on 19 August 2015

Management of cold haemolytic syndrome

scientific article published on 11 June 2007

Management of induction failures in newly diagnosed transplant-eligible multiple myeloma

scientific article published on 10 September 2019

Management of macroglobulinaemia

scientific article published on 09 May 2017

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines

scientific article published on December 2009

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.

scientific article published on April 2013

Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond

scientific article published on 16 January 2017

Managing light chain deposition disease

article published in 2011

Managing monoclonal gammopathy-associated neuropathy

scientific article

Managing myeloma kidney

scientific article published on 01 December 2005

Managing myeloma of the kidney

scientific article published on 01 February 2007

Managing plasma cell leukemia

scientific article published on 01 January 2007

Managing tumor lysis syndrome in 2010.

scientific article published in February 2010

Mayo Clinic Experience With Allogeneic and Syngeneic Bone Marrow Transplantation, 1982 Through 1990 ⬇️

scientific article published on February 1, 1992

Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma

scientific article published on August 2006

Measurement of murine serum amyloid P component by rate nephelometry ⬇️

scientific article published on April 27, 1984

Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis

scientific article published on 14 January 2011

Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma

scientific article published on 01 May 2020

Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation

article

MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts.

scientific article published on 17 June 2011

Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling

article

Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis

scientific article published on 27 February 2019

Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation

scientific article

Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98).

scientific article

Multicentre versus single centre approach to rare diseases: The model of systemic light chain amyloidosis

article

Multicentric Castleman disease – a single center experience of treatment with a focus on autologous stem cell transplantation

Multiple Myeloma in the Time of COVID-19

scientific article published on 17 April 2020

Multiple myeloma - a cure within reach

scientific article published on 04 April 2018

Multiple myeloma after kidney transplantation

scientific article published on 7 December 2014

Multiple myeloma and kidney transplantation: the beginning of a new era

scientific article published on 01 March 2019

Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases

scientific article published in May 1998

Multiple myeloma associated with diffuse osteosclerotic bone lesions: A clinical entity distinct from osteosclerotic myeloma (POEMS syndrome) ⬇️

scientific article published on December 1, 1997

Multiple myeloma: biology, standard therapy, and transplant therapy

scientific article published on January 2009

Myeloablative chemotherapy and stem cell transplantation in myeloma or primary amyloidosis with renal involvement

scientific article

Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report

scientific article

Myeloma and the newly diagnosed patient: a focus on treatment and management

scientific article

Myelomatous Involvement of the Central Nervous System

scientific article

Myopathy in primary systemic amyloidosis

scientific article

N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma

scientific article published on 10 August 2016

Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System

scientific article

Natural history and therapy of 66 patients with mixed cryoglobulinemia

scientific article published in July 2006

Natural history of amyloidosis isolated to fat and bone marrow aspirate

scientific article published on 22 June 2016

Natural history of multiple myeloma with de novo del(17p)

scholarly article by Arjun Lakshman et al published 7 March 2019 in Blood Cancer Journal

Natural history of t(11;14) multiple myeloma

scientific article

Natural history of thromboembolism in AL amyloidosis

scientific article

Nephelometric measurement of human serum amyloid P component (SAP)

scientific article published on 01 November 1983

Nephelometric measurement of human serum prealbumin and correlation with acute-phase proteins CRP and SAA: results in familial amyloid polyneuropathy

scientific article published on 01 October 1984

New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes

scientific article published on 22 October 2012

New developments in diagnosis, risk assessment and management in systemic amyloidosis

scientific article published on 02 November 2019

New targets and treatments in multiple myeloma: Src family kinases as central regulators of disease progression

scientific article published on December 2008

Newer Therapies for Amyloid Cardiomyopathy

scientific article

Non-cardiac biopsy sites with high frequency of transthyretin amyloidosis

scientific article published on 05 December 2020

Non-transplant eligible multiple myeloma: deciphering optimal first line regimens

scientific article published on 24 January 2020

Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CII.

scientific article published on 13 June 2016

Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis

scientific article published on 28 December 2006

Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma

scientific article published in October 2007

OCULAR MANIFESTATIONS OF SYSTEMIC AMYLOIDOSIS.

scientific article published on 24 October 2017

Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis

scientific article

Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma

scientific article published on 11 March 2016

Ocular Manifestations of Familial Transthyretin Amyloidosis

scientific article published on 11 September 2017

Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease

scientific article published on 01 August 2002

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio

scientific article published on 26 September 2018

Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient

scientific article published on 01 March 2007

Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid-directed monoclonal antibody

scientific article published on 20 September 2016

Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders

scientific article published on 3 March 2008

Outcome of very young (≤40 years) patients with immunoglobulin light chain (AL) amyloidosis

Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant

scientific article published on 2 March 2014

Outcomes of Multiple Myeloma Patients with Del 17p Undergoing Autologous Stem Cell Transplantation

scientific article published on 17 October 2020

Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation

scientific article published on 4 July 2017

Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved

scientific article published on 02 May 2019

Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantation

scientific article published on 14 August 2017

Outcomes of patients with POEMS syndrome treated initially with radiation

scientific article

Outcomes of patients with renal monoclonal immunoglobulin deposition disease

scientific article published on 8 August 2016

Outcomes of primary refractory multiple myeloma and the impact of novel therapies

scientific article published on 27 July 2015

Outcomes with different administration schedules of Bortezomib in Bortezomib, Lenalidomide and dexamethasone (VRd) as first-line therapy in Multiple Myeloma

scientific article published on 16 December 2020

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

scientific article published on 12 March 2019

Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis

scientific article published on 09 June 2020

Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome

scholarly article by Ashley R Paquin et al published 11 December 2018 in Blood Cancer Journal

Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition

scientific article published on 8 March 2017

POEMS syndrome: definitions and long-term outcome

scientific article

Paclitaxel as the initial treatment of multiple myeloma: an Eastern Cooperative Oncology Group Study (E1A93)

scientific article published on 01 December 1998

Panobinostat in multiple myeloma

scientific article published on 12 November 2016

Partial response or better at six months is prognostic of superior progression-free survival in Waldenström macroglobulinaemia patients treated with ibrutinib

scientific article published on 18 November 2020

Pathophysiology and treatment of cardiac amyloidosis

scientific article

Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation

scientific article published on 01 June 2001

Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma

scientific article published on 13 December 2018

Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma.

scientific article published on September 1996

Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome

scientific article published on 23 January 2008

Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature

scientific article published on 27 July 2004

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma

scientific article published on 30 July 2018

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy

scientific article

Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib

scientific article

Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.

scientific article

Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma

scientific article

Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation

scientific article published on 20 March 2015

Phase II trial of alpha-tocopherol (vitamin E) in the treatment of primary systemic amyloidosis

scientific article published on 01 May 1990

Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis

scientific article published in June 1999

Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis

scientific article published on 01 July 1999

Phase II trial of recombinant interferon alfa-2 in the treatment of primary systemic amyloidosis

scientific article published on 01 October 1993

Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory Waldenstrom macroglobulinemia

scientific article

Phase III study comparing vincristine, doxorubicin (Adriamycin), and dexamethasone (VAD) chemotherapy with VAD plus recombinant interferon alfa-2 in refractory or relapsed multiple myeloma. An Eastern Cooperative Oncology Group study

scientific article published on 01 December 1995

Pitfalls in the diagnosis of primary amyloidosis

scientific article published on June 2010

Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma

article published in 2018

Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response

scientific article published on 07 August 2018

Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation

scientific article published on 19 April 2018

Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma

scientific article published on 01 May 1999

Ploidy status rarely changes in myeloma patients at disease progression.

scientific article

Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM).

scientific article

Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma

scientific article

Pomalidomide and myeloma meningitis

scientific article

Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease

scientific article published on 20 June 2011

Pomalidomide, Bortezomib and Dexamethasone (PVD) for Patients with Relapsed, Lenalidomide Refractory Multiple Myeloma

scientific article

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial

scientific article published on September 2017

Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis

scientific article published in December 2003

Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy.

scientific article

Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review

scientific article

Potential new risks of lenalidomide

scientific article published on 28 January 2014

Pre-Existing Melanoma and Hematological Malignancies, Prognosis and Timing to Solid Organ Transplantation: A Consensus Expert Opinion Statement

scientific article published on 25 September 2020

Pre-Transplant Solid Organ Malignancy and Organ Transplant Candidacy: A Consensus Expert Opinion Statement

scientific article published on 24 September 2020

Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.

scientific article

Prediction of poor mobilization of autologous CD34+ cells with growth factor in multiple myeloma patients: implications for risk-stratification

scientific article published on 6 November 2013

Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study

scientific article published on 10 April 2008

Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma

scientific article published on 6 July 2015

Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosis

scientific article

Predictors of short-term survival in Waldenström Macroglobulinemia

scientific article published on 14 July 2020

Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia

scientific article published on 02 October 2018

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience

scientific article published on 5 May 2017

Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis

scientific article published on 24 April 2017

Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.

scientific article published in September 2003

Primary amyloidosis (AL) in families

scientific article published on 01 June 1986

Primary localized amyloidosis of the bladder: experience with dimethyl sulfoxide therapy

scientific article

Primary systemic amyloidosis

scientific article published on 01 June 2002

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

scientific article published on 12 October 2018

Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica

scientific article published on 01 November 1994

Primary systemic amyloidosis presenting with asymmetric multiple mononeuropathies

scientific article published on 20 April 2010

Primary systemic amyloidosis with delayed progression to multiple myeloma

scientific article published on 01 April 1998

Primary systemic amyloidosis--a diagnostic primer

scientific article

Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine

scientific article published on 01 December 1985

Primary systemic amyloidosis: a cause of malabsorption syndrome ⬇️

scientific article published on 01 November 2001

Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström's macroglobulinemia

scientific article published on 01 May 1993

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

scientific article

Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy

scientific article published on 01 March 1998

Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation

scientific article published on 15 May 2020

Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis

scientific article published on 02 February 2019

Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis

scientific article published on 30 June 2018

Prognostic Value of Circulating Plasma Cells in Monoclonal Gammopathy of Undetermined Significance

article

Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: An update of a US intergroup trial (SW0G S9003) ⬇️

scientific article published on April 1, 2003

Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003).

scientific article published in July 2001

Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.

scientific article

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma

scientific article published in September 2017

Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia

scientific article

Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis

scientific article published on 08 February 2019

Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis

scientific article published on 21 February 2018

Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance

scientific article published on 30 January 2018

Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantation

scientific article published on 04 July 2020

Prognostic value of angiogenesis in solitary bone plasmacytoma

scientific article published on 17 October 2002

Prognostic value of bone marrow angiogenesis in multiple myeloma

scientific article published on 01 August 2000

Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.

scientific article published in August 2004

Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma

scientific article published on 05 October 2006

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy

scientific article published on 30 April 2019

Prognostic value of urinary protein in primary systemic amyloidosis (AL)

scientific article published on 01 September 1990

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

scientific article published on 25 March 2004

Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease

scientific article

Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis

scientific article published on 01 January 1999

Proteasome Inhibitor-Related Cardiotoxicity: Mechanisms, Diagnosis, and Management

scientific article published on 08 June 2020

Proteomic Analysis of Waldenstrom Macroglobulinemia

article

Pulmonary marginal zone lymphoma of MALT type as a cause of localised pulmonary amyloidosis

scientific article

Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression

scientific article published on 26 July 2016

Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.

scientific article

Quantification of clonal circulating plasma cells in relapsed multiple myeloma

scientific article

Quantitative analysis of clonal bone marrow CD19+ B cells: use of B cell lineage trees to delineate their role in the pathogenesis of light chain amyloidosis

scientific article published on 3 March 2006

Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis

scientific article

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

scientific article published on 4 October 2016

Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method

scientific article published on 08 January 2019

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis

scientific article

Recent Advances in the Diagnosis, Risk Stratification, and Management of Systemic Light-Chain Amyloidosis

scientific article published on 16 January 2019

Recent advances in the diagnosis and management of cardiac amyloidosis

scientific article published on January 2014

Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score

scientific article

Recognition of congestive heart failure due to senile cardiac amyloidosis

scientific article published on 01 January 1989

Reducing neurotoxicity in the management of multiple myeloma ⬇️

scientific article published on August 18, 2011

Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis

scientific article published on 10 September 2012

Refining amyloid complete hematological response: quantitative serum free light chains superior to ratio

scientific article published on 18 July 2020

Refractory and relapsing multiple myeloma treated by blood stem cell transplantation

scientific article published on 01 March 1995

Refractory atypical hemolytic uremic syndrome with monoclonal gammopathy responsive to bortezomib-based therapy

scientific article

Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse

scientific article published on 15 October 2018

Relationship Between Depth of Response and Outcome in Multiple Myeloma

scientific article published on 01 November 2007

Relevant prognostic features of multiple myeloma and the new International Staging System

scientific article published on March 2007

Remission of disseminated cancer after systemic oncolytic virotherapy

scientific article

Renal apolipoprotein A-I amyloidosis associated with a novel mutant Leu64Pro

scientific article published in December 2004

Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis

scientific article

Reply

scientific article published on 13 December 2017

Reply to Castillo et al.

scientific article published on 5 January 2018

Reply to S. Girnius et al.

scientific article published in July 2013

Residual serum monoclonal protein predicts progression-free survival in patients with previously untreated multiple myeloma

scientific article

Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop

scientific article

Response of primary hepatic amyloidosis to melphalan and prednisone: a case report and review of the literature

scientific article

Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma

scientific article published in January 2003

Response rates and survival in primary systemic amyloidosis

scientific article published on 01 January 1991

Response to rituximab in patients with type II cryoglobulinemia

scientific article published on 01 September 2006

Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy

scientific article published on 11 October 2011

Restrictive Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy

scientific article published in September 2017

Retroperitoneal involvement with light chain amyloidosis- case series and literature review

scientific article published on 29 October 2020

Retrospective cohort study of 148 patients with polyclonal gammopathy

scientific article

Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion

scientific article published in February 1994

Review of 1027 patients with newly diagnosed multiple myeloma

scientific article

Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma

scholarly article by Praful Ravi et al published 15 November 2018 in Blood Cancer Journal

Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements

scientific article published on 13 February 2012

Revisiting complete response in light chain amyloidosis

scientific article published on 26 November 2019

Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival

scientific article published on 10 April 2017

Risk adapted post-transplant maintenance in multiple myeloma

scientific article published on 01 February 2019

Risk adapted therapy for multiple myeloma: back to basics

scientific article published on 22 April 2014

Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment

scientific article published on 16 December 2015

Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era.

scientific article published on 16 December 2016

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria.

scientific article

Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate

scientific article published on 01 December 2004

Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis

scientific article published in February 2010

SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalization

scientific article published on 25 October 2010

Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma

scientific article published in January 2018

Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation

scientific article published on 02 November 2018

Salvage autologous stem cell transplant is an effective regimen for relapsed multiple myeloma ⬇️

scientific article published on April 17, 2013

Second auto-SCT for treatment of relapsed multiple myeloma

scientific article published on 24 September 2012

Secondary malignancies in patients with multiple myeloma, Waldenström macroglobulinemia and monoclonal gammopathy of undetermined significance

scientific article

Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma

scientific article

Secondary systemic amyloidosis: response and survival in 64 patients

scientific article published on July 1991

Selecting Initial Therapy for Newly Diagnosed Waldenström Macroglobulinemia

scientific article published on 27 July 2018

Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation

scientific article published on 4 May 2017

Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest?

scientific article published on 01 November 1995

Serum M-spike and transplant outcome in patients with multiple myeloma.

scientific article

Serum amyloid A protein and C-reactive protein in systemic amyloidosis

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

scientific article published in September 2004

Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein

scientific article published on 15 August 2018

Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemia

scientific article published on 01 June 2008

Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome

scientific article

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

scientific article

Serum uric acid: novel prognostic factor in primary systemic amyloidosis

scientific article

Severity of Baseline Proteinuria Predicts Renal Response in Immunoglobulin Light Chain-Associated Amyloidosis after Autologous Stem Cell Transplantation

scientific article published on 04 April 2007

Shining a warm light on cryoglobulinemia

scientific article published in November 2013

Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma

scientific article published on 01 September 2004

Smoldering multiple myeloma requiring treatment: time for a new definition?

scientific article

Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T.

scientific article

Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses

scientific article

Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay

scientific article published on 13 December 2018

Stem Cell Mobilization and Autologous Transplant for Immunoglobulin Light-Chain Amyloidosis

scientific article published on 12 September 2020

Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time

scientific article published on 20 March 2018

Stem cell transplant for Waldenström macroglobulinemia: an underutilized technique ⬇️

scientific article published on August 29, 2011

Stem cell transplant: an effective salvage therapy for multiple myeloma ⬇️

scientific article published on June 12, 2011

Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosis

scientific article published on 03 May 2016

Stem cell transplantation for immunoglobulin light chain amyloidosis

scientific article

Stem cell transplantation for the management of primary systemic amyloidosis

scientific article

Stem cell transplantation in multiple myeloma: impact of response failure with thalidomide or lenalidomide induction

scientific article published on 20 January 2010

Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosis

scientific article published on 01 March 2010

Substratification of patients with newly diagnosed standard-risk multiple myeloma

scientific article published on 15 February 2019

Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation

scientific article

Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation

scientific article published in October 2005

Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study

scientific article published on 22 January 2004

Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis

scientific article published on 23 September 2019

Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins

scientific article

Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis

scientific article

Synovial fluid analysis for diagnosis of amyloid arthropathy

Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients

scientific article

Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review

scientific article published on 01 July 2020

Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome

scientific article published on October 2016

Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma

scientific article published on 19 March 2013

Systemic amyloidosis from A (AA) to T (ATTR): a review

scientific article published on 14 September 2020

Systemic immunoglobulin light chain amyloidosis

TTR gene silencing therapy in post liver transplant hereditary ATTR amyloidosis patients

scientific article published on 24 June 2020

Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosis

scientific article

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern

scientific article published on 12 July 2019

Testicular plasmacytoma: unique location or circumstantial presentation?

scientific article published on 9 January 2018

Tetraploidy is associated with poor prognosis at diagnosis in multiple myeloma

scientific article published on 06 February 2019

Thalidomide as initial therapy for early-stage myeloma

scientific article published in April 2003

Thalidomide for previously untreated indolent or smoldering multiple myeloma

scientific article published in August 2001

Thalidomide in the treatment of relapsed multiple myeloma

scientific article published on 01 September 2000

The Classification and Typing of Amyloid Deposits

The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors

scientific article published on 16 July 2019

The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis

scientific article

The classification and typing of amyloid deposits

scientific article published in June 2004

The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance

scientific article published on 01 September 2019

The colorful landscape of multiple myeloma

scientific article published on 27 February 2019

The current landscape of multiple myeloma treatment

scientific article

The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis

scientific article

The dilemma of jaw osteonecrosis in patients with multiple myeloma

scientific article published in November 2008

The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma

scientific article published on June 2004

The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma

scientific article published on September 2005

The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation

scientific article published on 30 November 2015

The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agents.

scientific article

The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma

scientific article published on 12 June 2019

The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma

scientific article published on 29 July 2009

The importance of bone marrow examination in patients with light chain amyloidosis achieving a complete response

scientific article published on 30 January 2018

The importance of immunoparesis in multiple myeloma

scientific article published on 25 December 2020

The plasma cell labeling index: a valuable tool in primary systemic amyloidosis

scientific article published on 01 August 1989

The premortem recognition of systemic senile amyloidosis with cardiac involvement

scientific article published in October 1996

The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma

scientific article published on 10 March 2016

The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma

scientific article published on 31 May 2017

The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment

scientific article

The role of bendamustine in the management of plasma cell myeloma

scientific article

The role of bisphosphonate therapy in the global management of multiple myeloma ⬇️

scientific article published on March 14, 2011

The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?

scientific article published on 06 May 2020

The role of high-dose chemotherapy followed by peripheral blood stem cell transplantation for the treatment of multiple myeloma

scientific article published on August 2008

The role of phosphatase and tensin homolog deleted on chromosome 10 and focal adhesion kinase in aggressive multiple myeloma ⬇️

scientific article published on January 31, 2012

The role of stem cell transplantation in Waldenstrom's macroglobulinemia

scientific article published on June 2016

The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry

scientific article published on 25 June 2019

The spectrum of monoclonal gammopathies affecting the kidney

scientific article published on 04 May 2012

The use of cell lines for the study of Waldenström's macroglobulinemia

scientific article published on 03 June 2008

The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome

scientific article published on 31 August 2011

Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy

scientific article published on 10 March 2017

Therapy for immunoglobulin light chain amyloidosis: the new and the old.

scientific article published on March 2004

Therapy of Transthyretin Cardiomyopathy

scientific article published on 01 July 2019

Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agents

article

Thermal stability threshold for amyloid formation in light chain amyloidosis

scientific article

Thrombotic microangiopathy during peripheral blood stem cell mobilization

scientific article

Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.

scientific article published on 16 April 2018

Transient acantholytic dermatosis associated with lymphomatous angioimmunoblastic lymphadenopathy.

scientific article

Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.

scientific article published on 11 February 2009

Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis

scientific article published on 01 October 2001

Transplantation for IgM amyloidosis and IgM myeloma

scientific article published on March 2009

Transplantation for amyloidosis

scientific article published on March 2007

Transplantation for multiple myeloma. Pertinent Questions

scientific article published on 01 November 2003

Transplantation without growth factor: engraftment kinetics after stem cell transplantation for primary systemic amyloidosis (AL).

scientific article published on 10 September 2007

Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?

scientific article published on 16 July 2016

Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia

scientific article published on 15 October 2020

Treatment of Castleman's disease

scientific article

Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

scientific article published on August 2015

Treatment of POEMS syndrome

scientific article published on June 2004

Treatment of immunoglobulin light chain (primary or AL) amyloidosis.

scientific article published on June 2011

Treatment of immunoglobulin light chain amyloidosis

scientific article published on April 2009

Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement

scientific article published on March 2007

Treatment of primary systemic amyloidosis (AL): role of intensive and standard therapy

scientific article published on 01 October 2012

Treatment of refractory multiple myeloma and considerations for future therapy

scientific article

Treatment options for POEMS syndrome

scientific article

Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis

scientific article published on 17 March 2017

Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

scientific article

Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia

scientific article published on 18 July 2016

Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

scientific article

Trend toward improved day 100 and two-year survival following stem cell transplantation for AL: a comparison before and after 2006 ⬇️

scientific article published on June 1, 2011

Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic

scientific article published on 02 April 2015

Trends and outcomes of modern staging of solitary plasmacytoma of bone

scientific article published on 2 May 2012

Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006.

scientific article

Trends in survival of patients with primary plasma cell leukemia: a population-based analysis

scientific article

Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics

scientific article published on 10 January 2012

Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis

scientific article

Troponin in hematologic oncology

scientific article published on February 2008

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

scientific article published on 13 July 2006

Two types of amyloidosis presenting in a single patient: a case series

scientific article published on 05 March 2019

Two-dimensional acoustic pattern derived strain parameters closely correlate with one-dimensional tissue Doppler derived strain measurements

scientific article published on 9 September 2005

Unravelling hypothyroidism in AL amyloidosis: Authors' reply.

scientific article

Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia

scientific article

Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia

scientific article published on December 2008

Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia

scientific article published on 12 January 2006

Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases

scientific article

Use of Beta Blockers is Associated with Survival Outcome of Multiple Myeloma Patients Treated with Pomalidomide

scientific article published on 01 December 2020

Use of autologous stem cells cryopreserved for over 15 years in stem cell transplantation for multiple myeloma

scientific article published on 11 November 2020

Using Novel Agents and Stem Cell Transplantation to Optimally Manage Immunoglobulin Light Chain Amyloidosis

scientific article published on 18 April 2015

Utility and prognostic value of 18 F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma

scientific article published on 02 October 2018

Utility of Doppler myocardial imaging, cardiac biomarkers, and clonal immunoglobulin genes to assess left ventricular performance and stratify risk following peripheral blood stem cell transplantation in patients with systemic light chain amyloidosi

scientific article

Utility of gallium imaging of the kidneys in diagnosing primary amyloid nephrotic syndrome

scientific article published on 01 March 1990

Utility of immunophenotyping of plasma cells in multiple myeloma

scientific article published on 28 October 2015

Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myeloma

scientific article published on 02 October 2020

Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy

scientific article

Utility of serum free light chain ratio in response definition in patients with multiple myeloma

scientific article published on 01 January 2020

Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain)

scientific article published on 01 April 1988

Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis

scientific article published on 01 June 1987

Utility of the immunoglobulin free light chain assay for plasma cell disorders 2015.

scientific article published on 11 March 2015

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.

scientific article

Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia

scientific article published on 04 March 2020

V122I Transthyretin Cardiomyopathy: An Opportunity to Build Trust and Resolve Disparities

scientific article published on 01 July 2020

Validation of Mayo Clinic Staging System for Light Chain Amyloidosis With High-Sensitivity Troponin

scientific article published on 15 November 2018

Vascular abnormalities in primary amyloidosis

scientific article published on 12 April 2007

Venetoclax for the treatment of multiple myeloma

scientific article published on 06 December 2018

Venetoclax for the treatment of translocation (11;14) AL amyloidosis

scientific article published on 11 May 2020

Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator

scientific article published in November 2002

Vinblastine-Loaded Platelets for Autoimmune Hemolytic Anemia

scientific article published on 01 September 1981

Waldenstrom's macroglobulinemia in the era of immunotherapy

scientific article published on 21 January 2020

Waldenström Macroglobulinemia: 2012 update on diagnosis, risk stratification, and management ⬇️

scientific article published on May 1, 2012

Waldenström Macroglobulinemia: 2020 Update on Diagnosis, Risk Stratification, and Management

scientific article published on 24 December 2020

Waldenström macroglobulinaemia.

scientific article published on November 2003

Waldenström macroglobulinaemia: the key questions.

scientific article published on 08 May 2013

Waldenström macroglobulinemia

scientific article published on 15 February 2007

Waldenström macroglobulinemia

scientific article published in January 2015

Waldenström macroglobulinemia treatment algorithm 2018.

scientific article

Waldenström macroglobulinemia.

scientific article

Waldenström macroglobulinemia: 2011 update on diagnosis, risk stratification, and management ⬇️

scientific article published on May 1, 2011

Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management ⬇️

scientific article published on June 20, 2013

Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management

scientific article

Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management

scientific article

Waldenström macroglobulinemia: 2018 update on diagnosis, risk stratification, and management

scientific article published on 17 October 2018

Waldenström macroglobulinemia: a review of therapy

scientific article

Waldenström macroglobulinemia: is newer really better? ⬇️

scientific article published on November 11, 2010

Waldenström macroglobulinemia: my way ⬇️

scientific article published on August 25, 2012

Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil

scientific article published on March 2000

Waldenström's macroglobulinemia

scientific article published on 01 January 2000

Waldenström's macroglobulinemia: a review of therapy

scientific article

What do I need to know about immunoglobulin light chain (AL) amyloidosis?

scientific article published on 25 April 2012

What is Waldenström macroglobulinemia? ⬇️

scientific article published on July 29, 2013

What is the correct philosophy for the treatment of multiple myeloma?

scientific article

What's new in Waldenström macroglobulinemia ⬇️

scientific article published on October 1, 2010

When is myeloma, myeloma?

scientific article published on 01 August 2006

When to Suspect a Diagnosis of Amyloidosis

scientific article published on 27 April 2020

When to recommend allogeneic transplant in multiple myeloma

scientific article published on 20 May 2015

Will we be able to afford a cure in multiple myeloma?

scientific article published on 20 June 2017

Worldwide Perspectives of Amyloidosis

scientific article published on 15 July 2020

Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents

scientific article (publication date: June 1985)

Yield of Noncardiac Biopsy for the Diagnosis of Transthyretin Cardiac Amyloidosis

scientific article published on 02 March 2014

You should see the other guy ⬇️

scientific article published on September 30, 2010

Paulina is supported by:

About Paulina

Help